Search Results - "Vos, M.Caroline"

The ENSURE trial for women with low-risk, early-stage endometrial cancer: A randomized controlled trial comparing the effect of a reduced (4 visits/3 yr) versus usual (8-11 visits/3 yr) follow-up schedule on patient satisfaction, health care use, and disease perception by van de Poll-Franse, Lonneke, de Rooij, Belle H, Creutzberg, Carien L., Kruitwagen, Roy F.P.M., Van Lonkhuijzen, Luc, Apperloo, Mirjam, Gerestein, C G, Baalbergen, Astrid, Boll, Dorry, Vos, M.Caroline, Ezendam, Nicole PM

“…5586 Background: Research suggests that most early-stage endometrial cancer patients do not need intensive follow-up to detect recurrences, improve survival,…”
Get full text

Identification of signal transduction pathway activity with potential clinical target in high-grade serous ovarian and tubal carcinoma by van der Ploeg, Phyllis, van Lieshout, Laura A.M., Wesseling-Rozendaal, Yvonne J.W., Van De Stolpe, Anja, Bosch, Steven L., Lentjes-Beer, Marjolein H.F.M., van Diest, Paul J., Vos, M.Caroline, De Hullu, Joanne, Bekkers, Ruud L.M., Piek, Jurgen M.J.

“…Abstract only e17541 Background: High-grade serous carcinoma (HGSC) is the most common subtype of epithelial ovarian and tubal cancer. It has a high mortality…”
Get full text

Evaluation of patient decision aid for opportunistic salpingectomy and salpingectomy as sterilization method to prevent ovarian cancer by Gelderblom, Malou, Piek, Jurgen M.J., Briet, J, Bullens, Lauren, Coppus, Sjors, Ebisch, Inge, van Ginkel, Alexandra, van de Laar, Rafli, de Lange, Natascha, Ngo, Huy, Maassen, Marloes, Oei, Angele, Pijlman, Brenda, Slangen, Brigitte, Smedts, Dineke, Vos, M.Caroline, De Hullu, Joanne, Hermens, Rosella

“…379 Background: The fallopian tubes play an important role in the pathogenesis of epithelial ovarian cancer. This has led to recommendations for performing…”
Get full text

Proteolysis of human apolipoprotein B: effect on quantitative immunoturbidimetry by De Bruin, T W, Vos, M C, Kortlandt, W, Bouma, B N, Erkelens, D W

“…Apolipoprotein (Apo) B100 is the obligatory structural protein of low and very low density lipoproteins. We studied the appearance of a kallikrein-induced…”
Get more information